Skip to main content

Table 2 Summary of measures

From: Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study

Variables and Their measurement

Respondent

T1

T2

T3

T4

T5

Aim 1: Feasibility

      

Process Evaluation Checklist

Project Manager

 

X

X

X

 

Intervention Session Evaluation

Mothers

X

X

X

X

 

Screening and Enrollment logs

Project Manager & Research Assistants

X

    

Field Notes

Interventionists & Research Assistants

X

X

X

X

X

Intervention Attendance

Interventionists

X

X

X

X

 

Data Collection Attendance

Research Assistants

X

X

X

X

X

Exit Interview

Mothers

    

X

Aim 2: Maternal Outcomes

      

Metabolic and Clinical Outcomes

      

3 hour Oral Glucose Tolerance Test 1 (FBG)

Mothers

X

    

2 hour Oral Glucose Tolerance Test 2 (FBG)

Mothers

 

X

  

X

Insulin Level and HOMA-IR

Mothers

X

X

  

X

A1C and Lipid Panel

Mothers

X

   

X

Blood Pressure

Mothers

X

X

X

X

X

Weight Status Outcomes

      

Height, Weight, Body Mass Index

Mothers

X

X

X

X

X

Adiposity Outcomes

      

Waist Circumference

Mothers

*

X

X

X

X

Triceps & Subscapular Skinfolds

Mothers

X

X

X

X

X

Health Behavior Outcomes

      

Adult Health Behavior Survey

Mothers

X

X

X

X

X

Health Promoting Lifestyle Profile II

Mothers

X

X

X

X

X

Accelerometry for 7 days

Mothers

X

X

X

X

X

Self-Efficacy Outcomes

      

Eating Self-Efficacy Scale

Mothers

X

X

X

X

X

Exercise Self-Efficacy Scale

Mothers

X

X

X

X

X

Breastfeeding Self-Efficacy Scale

Mothers

X

X

X

X

X

Aim: 3 Infant Feeding and Growth

      

Weeks until breastfeeding stopped #

Mothers

 

X

X

X

X

Weeks exclusively breastfed #

Mothers

 

X

X

X

X

Intensity of breastfeeding #

Mothers

 

X

X

X

X

Weight-by-Length Z scores

Infants

 

X

X

X

X

Demographic Data

Mothers

X

    
  1. T1 (Baseline, at 22–36 weeks); T2 (6 weeks postpartum); T3 (4 months postpartum at completion of Phase I); T4 (7 months postpartum at completion of Phase II); T5 (10 months postpartum, after 3 months on their own); 1 3 hour OGTT performed as part of GDM diagnosis includes fasting, 1, 2, and 3 hour glucose after a 100 g load; 2 2 hour OGTT includes a fasting and 2 hour glucose after a 75 g glucose load; * Not done pregnant; # If a mother stops breastfeeding we will stop collecting data.